- Home
- CLGN vs MTEN Comparison
CLGN vs MTEN Comparison
Compare CLGN & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- MTEN
- Stock Information
- Founded
- CLGN 2004
- MTEN 2015
- Country
- CLGN Israel
- MTEN China
- Employees
- CLGN N/A
- MTEN N/A
- Industry
- CLGN Industrial Specialties
- MTEN Building Products
- Sector
- CLGN Health Care
- MTEN Industrials
- Exchange
- CLGN Nasdaq
- MTEN Nasdaq
- Market Cap
- CLGN 33.8M
- MTEN 29.3M
- IPO Year
- CLGN N/A
- MTEN 2024
- Fundamental
- Price
- CLGN $2.07
- MTEN $2.23
- Analyst Decision
- CLGN Strong Buy
- MTEN
- Analyst Count
- CLGN 2
- MTEN 0
- Target Price
- CLGN $11.50
- MTEN N/A
- AVG Volume (30 Days)
- CLGN 34.5K
- MTEN 113.5K
- Earning Date
- CLGN 11-26-2025
- MTEN 10-01-2025
- Dividend Yield
- CLGN N/A
- MTEN N/A
- EPS Growth
- CLGN N/A
- MTEN N/A
- EPS
- CLGN N/A
- MTEN N/A
- Revenue
- CLGN $2,402,000.00
- MTEN $10,735,337.00
- Revenue This Year
- CLGN $1,617.28
- MTEN N/A
- Revenue Next Year
- CLGN $83.54
- MTEN N/A
- P/E Ratio
- CLGN N/A
- MTEN N/A
- Revenue Growth
- CLGN 248.62
- MTEN 16.63
- 52 Week Low
- CLGN $1.31
- MTEN $2.22
- 52 Week High
- CLGN $4.98
- MTEN $26.03
- Technical
- Relative Strength Index (RSI)
- CLGN 37.05
- MTEN 22.59
- Support Level
- CLGN $2.12
- MTEN $2.32
- Resistance Level
- CLGN $2.27
- MTEN $2.91
- Average True Range (ATR)
- CLGN 0.13
- MTEN 0.66
- MACD
- CLGN -0.01
- MTEN 0.01
- Stochastic Oscillator
- CLGN 0.00
- MTEN 1.92
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.